Biocartis Raises €30 Million
Biocartis SA, a Swiss developer of personalized medicine diagnostics, has raised €30 million in Series B funding. Debiopharm Group and and Johnson & Johnson Development Corp. were joined on the round by return backers Aescap, Biovest, Advent Venture Partners and company employees.
8 April 2010•4 mins read
